On 12/31/21, John transitioned CEO leadership of Alnylam to Yvonne Greenstreet. Maraganore was Chair of the Biotechnology Innovation Organization (BIO) from The Top 10 Highest-Paid Women Executives in Biopharma
John M. Maraganore: Independent Director. Michel Orsinger: Independent Net Income. 107,928.00. 2025 (millions USD). Income Statement table. Balance John Maraganore, PhD, the CEO of Alnylam Pharmaceuticals; and Halozyme president and CEO Helen Torley, then-chair of BIO's committee on value. Since his departure at Alnylam, Maraganore is the principal of JMM Innovation, LLC, committed to the advancement of transformative medicines to
This biotech CEO is going all-in on a first drug approval Alnylam Chief Makes Pricing Pledges Before Drug Is Even Approved
Chief Executive John Maraganore makes a pledge: "We will not Net Worth List · When Teens Fundraise To End Blood Cancer, They Change John Maraganore Net Worth (2025) John Maraganore - Wikipedia
John Maraganore Net Worth - Insider Trades and Bio as of Dec 3 2007 was John Maraganore's most active year for disposing of shares, totalling 123 transactions. John Maraganore's most active month to dispose stocks was the (TAK) | Stock Price & Latest News | Reuters
John Maraganore - Founding CEO at Alnylam Pharmaceuticals John Maraganore Net Worth. The estimated net worth of John Maraganore is at least $100 Million dollars as of 2025-12-08. John Maraganore is the CEO of Alnylam
John Maraganore, CEO of Alnylam Pharmaceuticals, in his office in Cambridge. Today, Alnylam is worth about $6 billion Alnylam founder John Maraganore snags $10.2M pay in his farewell
Alnylam modified the face value of Maraganore's stock options to reflect the additional value that will continue to vest through March 2024, a John Maraganore Net Worth John Maraganore has an estimated net worth of at least $83.4 million*, as of June 4, 2025. They own shares of ALNY stock. They have